Stephane Boissel

EVP, CORP. STRATEGY · SANGAMO THERAPEUTICS, INC · CIK 0001755198

FILING MIX · LIFETIME38%/62%

BUYS

SELLS

TOTAL VALUE

$183.6K

COMPANIES

ACTIVE SINCE

Feb 2020

HOLDINGS NOW

AVG SELL PX

$10.62

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Stephane Boissel. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

SGMO · 1 shares · as of Jul 3, 2020

Trading cadence · quarterly flow

BUY ● SELL ●

2020

FLOW · 3 buys / 5 sellsCOVERAGE · 3 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
SGMO SANGAMO THERAPEUTICS, INC	SALE EVP, Corp. Strategy	1	—	—	1	Jul 3, 2020	Jul 31, 2020 ↗	View →
SGMO SANGAMO THERAPEUTICS, INC	SALE EVP, Corp. Strategy	14,907	$11.23	$167.4K	70,116	Jun 4, 2020	Jun 5, 2020 ↗	View →
SGMO SANGAMO THERAPEUTICS, INC	SALE EVP, Corp. Strategy	1	—	—	2	Jun 4, 2020	Jun 5, 2020 ↗	View →
SGMO SANGAMO THERAPEUTICS, INC	PURCHASE EVP, Corp. Strategy	14,907	—	—	85,023	Jun 4, 2020	Jun 5, 2020 ↗	View →
SGMO SANGAMO THERAPEUTICS, INC	SALE EVP, Corp. Strategy	1	—	—	2	May 9, 2020	Jul 31, 2020 ↗	View →
SGMO SANGAMO THERAPEUTICS, INC	PURCHASEGRANT Stock grant	55,000	—	—	70,116	Feb 25, 2020	Feb 26, 2020 ↗	View →
SGMO SANGAMO THERAPEUTICS, INC	SALE EVP, Corp. Strategy	2,384	$6.80	$16.2K	15,116	Feb 25, 2020	Feb 26, 2020 ↗	View →
SGMO SANGAMO THERAPEUTICS, INC	PURCHASEGRANT Stock grant	110,000	—	—	110,000	Feb 25, 2020	Feb 26, 2020 ↗	View →

Other insiders · SGMO

Loading peer insiders…

About this filer

CIK 0001755198

ROLE

EVP, Corp. Strategy

PRIMARY

SGMO

COMPANIES

ACTIVE SINCE

Feb 2020

MARKETPEEL · /INSIDER/0001755198DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.